|
Statement
| 1.Name and nature of the underlying assets (if preferred shares,
the terms and conditions of issuance shall also be indicated,
e.g., dividend yield, etc.):Common stock of BioEngine Capital Inc.
2.Date of occurrence of the event:2022/04/01
3.Volume, unit price, and total monetary amount of the transaction:
Volume: 114,146,281 shares
Unit price:NTD 6.79 per share
Total monetary amount:NTD 775,053,247 million
4.Trading counterparty and its relationship to the Company
(if the trading counterparty is a natural person and
furthermore is not a related party of the Company, the name
of the trading counterparty is not required to be disclosed):
LCL Capital Inc.: Chairman of the company is a second-degree relatives of
Corporate Director representing Center Laboratories, Inc.
Witty Mate Corporation: Chairman of the company is a second-degree
relatives of Corporate Director representing Center Laboratories, Inc.
Yong Lien Corp.: Chairman of the company is a Director of Center
Laboratories, Inc.
Taiwan Land Investment Co.: Chairman of the company is an Independent
Director of Center Laboratories, Inc.
Mao Chang Biotechnology Co., Ltd.: Chairman of the company is spouse of an
Independent Director of Center Laboratories, Inc.
Collins Co., Ltd.: Chairman of the company is a Director of Center
Laboratories, Inc.
5.Where the trading counterparty is a related party,
announcement shall also be made of the reason for choosing
the related party as trading counterparty and the
identity of the previous owner, its relationship with
the Company and the trading counterparty, and the previous
date and monetary value of transfer:
The Company is purchasing stocks from the shareholders of Bioengine
CapitalInc. who are willing to sell their shares, and some of these
shareholders of Bioengine Capital Inc. are related party of the Company.
6.Where an owner of the underlying assets within the past
five years has been an related party of the Company, the
announcement shall also include the date and price of
acquisition and disposal by the related party, and its
relationship to the Company at the time of the transaction:NA
7.Matters related to the current disposal of creditors'
rights (including types of collaterals of the disposed
creditor's rights; if creditor's rights over a related
party, announcement shall be made of the name of the
related party and the book amount of the creditor's
rights, currently being disposed of, over such related
party:NA
8.Profit or loss from the disposal (not applicable in
cases of acquisition of securities) (where originally
deferred, the status of recognition shall be listed and
explained):NA
9.Terms of delivery or payment (including payment period
and monetary value), restrictive covenants in the contract,
and other important terms and conditions:
In accordance with contract terms.
10.The manner in which the current transaction was
decided, the reference basis for the decision on price,
and the decision-making unit:
According to the resolutions of the Board Meeting and
a reasonable opinion thereof made by an independent CPA.
11.Net worth per share of the Company's underlying securities
acquired or disposed of:NA
12.Cumulative no.of shares held (including the current
transaction), their monetary value, shareholding percentage,
and status of any restriction of rights (e.g., pledges),
as of the present moment:
Volume：458,834,283shares
Monetary value：NTD 1,610,053thousand
Shareholding percentage：78%
Any restriction of rights:None
13.Ratio of securities investment (including the current
transaction) to the total assets and shareholder's equity
of the parent company on the latest financial statements,
and the operating capital on the latest financial statements,
as of the present moment:
Ratio of securities investment to the total assets：78.3 %
Ratio of securities investment to the shareholder's equity：108.43 %
Operating capital：NTD 2,613,396thousand
14.Broker and broker's fee:None
15.Concrete purpose or use of the acquisition or disposal:
It's for the long-term strategic development and adjustment on the
shareholding structure of the group.
16.Whether the directors expressed any objection to the current
transaction:NO
17.Whether the counterparty of the current transaction
is a related party:Yes
18.Date of the Board of Directors' resolution:2022/04/01
19.Date of ratification by supervisors or approval by
the Audit Committee:2022/04/01
20.Whether the CPA issued an opinion on the unreasonableness
regarding the current transaction:NO
21.Name of the CPA firm:Trust and Assist CPAs
22.Name of the CPA:LIN CHANG YU
23.License no.of the CPA:Financial-Supervisory-Commission-4562
24.Any other matters that need to be specified:None
|
